Relation Between Obesity and Survival in Patients Hospitalized for Pulmonary Arterial Hypertension (from a Nationwide Inpatient Sample Database 2003 to 2011)

American Journal of Cardiology

Volumn 120, Issue 3, 2017, Pages 489-493

  Agarwal, Manyoo ^a   Agrawal, Sahil ^b   Garg, Lohit ^c   Lavie, Carl J ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST LUKE S UNIVERSITY HEALTH NETWORK   (United States)

^c LEHIGH VALLEY HOSPITAL   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; ELIXHAUSER COMORBIDITY INDEX; FEMALE; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ICD-9-CM; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; SURVIVAL RATE; CLINICAL TRIAL; COMPLICATION; INCIDENCE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TRENDS; UNITED STATES;

FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; INPATIENTS; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 85020446189     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2017.04.051     Document Type: Article

References (30)

1. Poirier, P., Giles, T.D., Bray, G.A., Hong, Y., Stern, J.S., Pi-Sunyer, F.X., Eckel, R.H., Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 26 (2006), 968–976.
2. Lainscak, M., von Haehling, S., Doehner, W., Sarc, I., Jeric, T., Ziherl, K., Kosnik, M., Anker, S.D., Suskovic, S., Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2 (2011), 81–86.
3. Fonarow, G.C., Srikanthan, P., Costanzo, M.R., Cintron, G.B., Lopatin, M., Committee, A.S.A., Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 (2007), 74–81.
4. Chittal, P., Babu, A.S., Lavie, C.J., Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease?. COPD 12 (2015), 14–18.
5. Lavie, C.J., Sharma, A., Alpert, M.A., De Schutter, A., Lopez-Jimenez, F., Milani, R.V., Ventura, H.O., Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 58 (2016), 393–400.
6. Uretsky, S., Messerli, F.H., Bangalore, S., Champion, A., Cooper-Dehoff, R.M., Zhou, Q., Pepine, C.J., Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120 (2007), 863–870.
7. Poms, A.D., Turner, M., Farber, H.W., Meltzer, L.A., McGoon, M.D., Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest 144 (2013), 169–176.
8. Benza, R.L., Gomberg-Maitland, M., Naeije, R., Arneson, C.P., Lang, I.M., Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. J Heart Lung Transplant 30 (2011), 982–989.
9. Zafrir, B., Adir, Y., Shehadeh, W., Shteinberg, M., Salman, N., Amir, O., The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox”. Respir Med 107 (2013), 139–146.
10. Robbins, I.M., Moore, T.M., Blaisdell, C.J., Abman, S.H., Improving outcomes for pulmonary vascular disease. Am J Respir Crit Care Med 185 (2012), 1015–1020.
11. Healthcare Cost and Utilization Project (HCUP). Overview of the National (nationwide) Inpatient Sample (NIS), Rockville. Available at: https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed on January 10, 2016.
12. Anand, V., Roy, S.S., Archer, S.L., Weir, E.K., Garg, S.K., Duval, S., Thenappan, T., Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: analysis of the nationwide inpatient sample database from 2001 through 2012. JAMA Cardiol 1 (2016), 1021–1029.
13. Elixhauser, A., Steiner, C., Harris, D.R., Coffey, R.M., Comorbidity measures for use with administrative data. Med Care 36 (1998), 8–27.
14. Alpert, M.A., Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321 (2001), 225–236.
15. Vasan, R.S., Cardiac function and obesity. Heart 89 (2003), 1127–1129.
16. Alpert, M.A., Omran, J., Mehra, A., Ardhanari, S., Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 56 (2014), 391–400.
17. Oktay, A.A., Lavie, C.J., Milani, R.V., Ventura, H.O., Gilliland, Y.E., Shah, S., Cash, M.E., Current perspectives on left ventricular geometry in systemic hypertension. Prog Cardiovasc Dis 59 (2016), 235–246.
18. Diong, C., Jones, P.P., Tsuchimochi, H., Gray, E.A., Hughes, G., Inagaki, T., Bussey, C.T., Fujii, Y., Umetani, K., Shirai, M., Schwenke, D.O., Sympathetic hyper-excitation in obesity and pulmonary hypertension: physiological relevance to the ‘obesity paradox’. Int J Obes (Lond) 40 (2016), 938–946.
19. Lainscak, M., von Haehling, S., Doehner, W., Anker, S.D., The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 3 (2012), 1–4.
20. Parto, P., Lavie, C.J., Arena, R., Bond, S., Popovic, D., Ventura, H.O., Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox. Future Cardiol 12 (2016), 639–653.
21. Groth, A., Vrugt, B., Brock, M., Speich, R., Ulrich, S., Huber, L.C., Inflammatory cytokines in pulmonary hypertension. Respir Res, 15, 2014, 47.
22. Horwich, T.B., Fonarow, G.C., Hamilton, M.A., MacLellan, W.R., Woo, M.A., Tillisch, J.H., The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001), 789–795.
23. Lavie, C.J., Alpert, M.A., Arena, R., Mehra, M.R., Milani, R.V., Ventura, H.O., Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 1 (2013), 93–102.
24. Bastien, M., Poirier, P., Lemieux, I., Despres, J.P., Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 56 (2014), 369–381.
25. Taraseviciute, A., Voelkel, N.F., Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res 11 (2006), 198–202.
26. Badesch, D.B., Raskob, G.E., Elliott, C.G., Krichman, A.M., Farber, H.W., Frost, A.E., Barst, R.J., Benza, R.L., Liou, T.G., Turner, M., Giles, S., Feldkircher, K., Miller, D.P., McGoon, M.D., Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 137 (2010), 376–387.
27. Al Kazzi, E.S., Lau, B., Li, T., Schneider, E.B., Makary, M.A., Hutfless, S., Differences in the prevalence of obesity, smoking and alcohol in the United States nationwide inpatient sample and the Behavioral Risk Factor Surveillance System. PLoS One, 10, 2015, e0140165.
28. Arena, R., Lavie, C.J., Borghi-Silva, A., Daugherty, J., Bond, S., Phillips, S.A., Guazzi, M., Exercise training in group 2 pulmonary hypertension: which intensity and what modality. Prog Cardiovasc Dis 59 (2016), 87–94.
29. Lavie, C.J., De Schutter, A., Parto, P., Jahangir, E., Kokkinos, P., Ortega, F.B., Arena, R., Milani, R.V., Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated. Prog Cardiovasc Dis 58 (2016), 537–547.
30. Lavie, C.J., McAuley, P.A., Church, T.S., Milani, R.V., Blair, S.N., Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 63 (2014), 1345–1354.